A Critical Role for the mTORC2 Pathway in Lung Fibrosis

• Wenteh Chang,

  Affiliation Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Ke Wei,

  Affiliation Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Lawrence Ho,

  Affiliation Division of Pulmonary and Critical Care Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America

  ⨯
• Gerald J. Berry,

  Affiliation Department of Pathology, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Susan S. Jacobs,

  Affiliation Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Cheryl H. Chang,

  Affiliation Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Glenn D. Rosen

  * E-mail: grosen@stanford.edu

  Affiliation Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯